Zai Lab Sustainability Profile
Zai Lab Limited, commonly referred to as Zai Lab, is a prominent biopharmaceutical company headquartered in China. Founded in 2014, the company has rapidly established itself as a leader in the development of innovative therapies, focusing primarily on oncology, autoimmune diseases, and infectious diseases. With a strong operational presence in both China and the United States, Zai Lab is committed to addressing unmet medical needs through its robust pipeline of novel drug candidates. The company’s core offerings include a range of proprietary and partnered products, distinguished by their unique mechanisms of action and potential to improve patient outcomes. Zai Lab has achieved significant milestones, including successful collaborations with global pharmaceutical leaders and the launch of several key therapies in the Chinese market. Recognised for its commitment to innovation, Zai Lab continues to strengthen its position in the competitive biopharmaceutical landscape.
DitchCarbon Score
How does Zai Lab's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Zai Lab's score of 53 is higher than 69% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Zai Lab's reported carbon emissions
In 2024, Zai Lab reported total carbon emissions of approximately 59,814,000 kg CO2e, with Scope 1 emissions at about 294,000 kg CO2e, Scope 2 emissions at approximately 4,056,000 kg CO2e, and a significant contribution from Scope 3 emissions, which totalled around 55,465,000 kg CO2e. The largest components of Scope 3 emissions included purchased goods and services (about 52,633,000 kg CO2e) and employee commuting (approximately 1,074,000 kg CO2e). In 2023, Zai Lab's total emissions were approximately 70,321,000 kg CO2e, with Scope 1 emissions at about 14,550 kg CO2e, Scope 2 emissions (location-based) at approximately 4,664,000 kg CO2e, and Scope 3 emissions reaching around 65,642,000 kg CO2e, primarily driven by purchased goods and services (about 55,213,110 kg CO2e). The company has shown a slight decrease in total emissions from 2022, where emissions were reported at approximately 74,436,000 kg CO2e. This reduction trend is notable, although specific reduction targets have not been established, as Zai Lab's near-term targets have been classified as "Commitment removed" and "Expired commitment" as of July 2023. Zai Lab's emissions data is not cascaded from any parent company, indicating that the reported figures are solely from Zai Lab Limited. The company is committed to addressing its carbon footprint, although it has not set a net-zero target or long-term reduction goals at this time.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|
| Scope 1 | 28,400 | 00,000 | 00,000 | 000,000 |
| Scope 2 | 3,536,600 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 3 | - | 00,000,000 | 00,000,000 | 00,000,000 |
How Carbon Intensive is Zai Lab's Industry?
How Carbon Intensive is Zai Lab's Location?
Zai Lab's Scope 3 Categories Breakdown
Zai Lab's Scope 3 emissions, which decreased by 16% last year and decreased by approximately 21% since 2022, demonstrating supply chain emissions tracking. The vast majority of their carbon footprint comes from suppliers and value chain emissions, representing the vast majority of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 95% of Scope 3 emissions.
Top Scope 3 Categories
Zai Lab's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Zai Lab has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
Frequently Asked Questions
Common questions about Zai Lab's sustainability data and climate commitments